Xenon Pharmaceuticals Inc
Price
OptionsOpen the Sheet →FilingsNewest: 10-Q, Quarterly reportAug 6 →InsidersNo open-market buys. 5 insiders sold $20.9M, all 23 sales on a 10b5-1 plan.→HoldersFMR 10.0%BlackRock 7.8%Avoro Capital 6.0%→Financing →PeersClosest companies: PRAX, ATAI, KYMR→
From the filings
Figures
- Revenue
- $0.00last 12 months
- Net income
- −$409.2Mlast 12 months
- Operating cash flow
- −$306.4Mlast 12 months
- Cash and equivalents
- $119.5Mat the last balance sheet
- Shares outstanding
- 96.8M shareson issue